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We have previously reported that Microthrottle Pumps (MTPs) display the 
capacity to pump solid phase suspensions such as polystyrene beads which 
prove challenging to most microfluidic pumps. In this paper we report 
employing a Linear Microthrottle Pump (LMTP) to pump whole, undiluted, 
anticoagulated, human venous blood at 200 µl.min-1 with minimal 
erythrocyte lysis and no observed pump blockage. LMTPs are particularly 
well suited to particle suspension transport by virtue of their relatively 
unimpeded internal flow-path. Micropumping of whole blood represents a 
rigorous real-world test of cell suspension transport given blood’s high cell 
content by volume and erythrocytes’ relative fragility.  A modification of the 
standard Drabkin’s method and its validation to spectrophotometrically 
quantify low levels of erythrocyte lysis by haemoglobin release is also 
reported. Erythrocyte lysis rates resulting from transport via LMTP are 
determined to be below one cell in five hundred at a pumping rate of 102 
µl.min-1. 
Introduction 
Blood Transport in Microfluidics 
Interest in blood cell transport and analysis in microfluidic devices extends back to the 
early 1990s and involved the development of precision cell-mechanical characterisation 
systems for biomechanical studies. The earliest application is by Kikuchi et al1 who 
reported a simple silicon micromachined flow cell used in the manner of a microfilter. 
We subsequently reported the use of a silicon-glass flow cell in conjunction with real-
time image processing to yield cell-by-cell cytomechanical indices for erythrocytes2.  
This research continued with the development of a complete instrument3 that was 
eventually employed to analyse limited clinical samples for medical conditions including 
Thalassaemia4.  The authors’ past experience in developing this relatively automated 
analysis system underlined the need for the careful handling of blood in order to avoid 
erythrocyte lysis within the microfluidics. Other related micromachined flow cells for 
cytomechanical studies, albeit without such extensive supporting instrumentation, were 
developed5. Papers have continued to appear in this area in more recent years6-9. 
The first report of blood transport by micropumping techniques was by Furdui et al10 
who adapted an electrolysis driven micropump11 resulting in a single delivery, ‘one-shot’, 
blood micropump employing gas bubble generation to displace a 7µl volume of blood 
into an analysis area. Recently, a triple actuator, silicon-glass, peristaltic pump for 
transport of blood samples has been reported12. The authors described the use of a self 
assembled monolayer to inhibit the binding of platelets to the silicon surface which might 
otherwise cause leucocyte activation. The authors proceed to report maximum blood 
pumping rates of 50 µl.min-1 and back pressures of 1.8 kPa which were significantly 
lower than the corresponding values obtained with water due to the increased viscosity of 
the analyte. 
The use of elastomeric microfluidic devices for other areas of blood cell handling8,13,14 
is becoming more common due to lower fabrication costs, ease of manufacture and 
biocompatibility15. As a result of these developments several composite micropumps, 
developed to be able to pump blood, have been reported incorporating elastomer as a 
fluid contact material16,17. The elastomer/glass composite micropump reported here, while 
not initially designed for biomedical purposes, utilises all of these features. 
Microthrottle and MTP Operating Principles 
As previously reported18, Microthrottle Pumps (MTPs) were developed to utilise 
‘throttling’: the use of variable cross-section flow-constrictions (microthrottles) to control 
fluid flow19. A detailed discussion of microthrottles, their application in microthrottle 
pumps and the operating principles of microthrottle pumps, has been made previously20, 
therefore only a brief summary is provided here. Microthrottles necessitate the use of an 
elastomeric material to enable the formation of a variable cross-section microchannel 
segment. Previous observations have confirmed, in agreement with Finite Element 
Modelling (FEM), that the microthrottle surfaces do not contact21 and, as intended, 
exhibit quite modest closed to open flow resistance ratios (8:1 in the latest throttle 
designs21).  However, despite their modest ratios, relative to conventional, fully closing 
valves, pumps incorporating a pair of such throttles demonstrate pumping efficiencies 
close to those of micropumps incorporating conventional, fully-closing valves20. In 
addition, as a result of the lack of full throttle closure, pumps utilising microthrottles have 
been demonstrated to be tolerant of high particle concentrations22 and are not affected by 
interfacial stiction, which is commonly exhibited if PDMS contacts another surface23, and 
are therefore capable of operating at high actuator frequencies (circa 1800 Hz), in the 
context of PDMS devices.  
Microthrottle Pumps (MTPs) 
Microthrottle Pumps utilise two microthrottles placed at the nodal (central) and anti-
nodal (peripheral) points of a single piezoelectric bimorph-disc driven actuation layer 
(Figure 1). Each pumping cycle occurs as a result of the constriction of the peripheral 
microthrottle with simultaneous expansion of the pump chamber (suction stroke). This is 
followed by constriction of the central microthrottle and compression of the pump 
chamber, with simultaneous opening of the peripheral microthrottle creating a low fluid 
resistance ouput path (pump stroke). 
 
Significant development of MTPs has occurred to enhance their operation. This 
evolution of MTPs has been presented previously24, and hence is only summarised here. 
Initial variants of the microthrottle pumps incorporated a defined pump chamber with 
throttles constricting normal to the axis of compression22. Subsequent developments 
included the use of throttles constricting parallel to the axis of compression implemented 
within double-depth structure22, providing enhanced throttling ratios via displacement 
Figure 1. Schematic of a single piezoelectrically actuated, double depth MTP operating cycle. The direction 
of pumping through the device is left to right. 
amplification20, and the utilisation of the inter-throttle region of the pump channel as the 
pump chamber21, thereby reducing undesirable recirculatory effects within pump 
chambers as reported by Andersson et al25. The resulting Linear Microthrottle Pumps 
(LMTP) demonstrated pumping rates up to 1.4 ml.min-1 and the ability to pump against a 
back pressure of 35 kPa of water21. 
Fabrication and Assembly 
The LMTP employed here has an optimised 1 mm wide, 100 µm deep channel with 20 
µm deep throttles, that is thus slightly different to those we have characterised and 
reported previously24. The refinement in this variant primarily involves a slightly 
increased throttle gap in order to ensure that erythrocyte’s are not ‘pinched’ in the 
compression stroke and thus potentially lysed. The overall device is of identical 
dimensions and employs an identical PZT (see definition below) bimorph actuator to 
previous MTPs. 
 
The LMTPs were fabricated and assembled in the manner we have previously described 
in detail20, which is briefly summarised here. Molds were microfabricated from SU8 
(Microchem Corp.) structural photoresist on silicon wafers. The PDMS microstructures 
were then cast in Dow Corning Sylgard® 184 PDMS processed in the, previously 
reported18, standard way (Figure 2). The LMTP was then assembled. Firstly a glass 
microscope slide was cut to size to form a back-plate and diamond drilled to provide fluid 
vias. A cover slip was then coated with chromium, by evaporation, to facilitate electrical 
connection to the piezoelectric actuator. The PDMS, cover slip and back-plate were then 
UV-Ozone treated, bonded, assembled and then baked at 90°C for 2 hours. The PZT (lead 
zirconate titanate) piezoelectric bimorph disc (Piezo Systems, T216-A4NO-273X) was 
then bonded to the cover slip with conductive epoxy adhesive and fine connecting wires 
were attached. An assembled LMTP is shown in Figure 3. 
Figure 2. PDMS LMTP substrate. Left is a photograph of the LMTP casting focusing on the structure while 
the right hand image shows a surface profile of one of the double depth throttles employed in the design. Also 
included in the surface profile image is the depth information provided by the surface profiler. 
Figure 3. An assembled LMTP. 
Blood Pumping Evaluation 
Blood Preparation 
Venous blood, taken from a single donor, was drawn into two 9 ml EDTA vacutainers 
(Griener Bio-one, Austria).  Care was taken to immediately agitate the sample in order to 
thoroughly disperse the precoated EDTA anticoagulant.  The contents of the vacutainers 
were combined, to ensure that inter-sample differences were eliminated, and kept at room 
temperature.  
The whole blood was then separated into two aliquots. One  aliquot for evaluation of 
the flow rate vs frequency performance of the LMTP and one aliquot for further division  
as required to provide samples for determination of the percentage erythrocyte lysis of the 
LMTP at selected actuator frequencies and voltages. Prior to all measurements the blood 
to be pumped was agitated gently to ensure an even suspension of all cellular material.  
Greater volumes of blood were contained within the fluid input reservoir than were 
required for each experiment.  This, combined with the diameter of the tubes used, the 
position of the input tube and the calculated maximum erythrocyte sedimentation rate of 
15 mm/hr for the donor26 indicated that cell sedimentation was insignificant over the 
experimental time period.  Therefore no agitation was required during individual 
experiments.  Following measurement of the flow rate / actuator frequency relationship, 
three samples were taken from the second aliquot of whole blood, with each being taken 
immediately prior to pumping, for measurement of percentage erythrocyte lysis.  As each 
sample was removed from the second aliquot for pumping, a second, identically sized, 
sample was removed and placed into a microcentrifuge tube to act as a reference sample 
for subsequent differential spectrophotometric comparison with the pumped sample to 
determine pump-induced lysis. 
Experimental  System 
All characterisations of pump performance were performed by mass transfer of either 
filtered DI water or freshly drawn, anticoagulated, whole blood from a reservoir placed 
on a precision microbalance (Sartorius 210s, Sartorius AG) with data processed in real 
time by software written in LabVIEW® (National Instruments) to obtain mass flow rate 
values. The volumetric flow rate was then calculated from the measured mass flow rate 
using a blood density of 1.05 g/ml at a room temperature of 22ºC27.  Fluid system 
preparation was as previously described22, however priming was performed with filtered, 
degassed phosphate buffered saline (PBS) rather than deionised water to avoid cell lysis 
at the interface between incoming blood and the priming solution.  The initial flow of 
blood through the fluid system was continued for 30 s, prior to any measurements, to 
ensure the complete removal of PBS.  All measurements of flow rate were conducted as 
previously described22 using bespoke drive electronics21 programmed to increase the 
drive frequency in increments of 100 Hz with a 30 s actuation period for each frequency.  
A 10 s pause between each incremental increase in frequency was included to enable 
confirmation that the flow rate reduced to zero following each measurement.  That is, that 
any slight change in relative fluid reservoir and waste height did not affect the initial set 
starting flow condition and that the LMTP exhibited no hysteresis.  Back pressure 
measurements were performed by measuring the rate of mass transfer from the fluid input 
bottle as a back pressure was applied to the fluid waste bottle following zeroing of the 
flow from the fluid input to fluid waste.  The back pressure was finely controlled and 
increased incrementally via a precision needle valve (Type 91, Marsh Bellofram Corp, 
WV, USA) while the applied pressure was measured using a digital pressure meter (DPI 
705, Druck, USA). The flow resistance of all input and output tubing was measured to 
enable accurate calculation of pump performance.  The height change of fluid levels were 
calculated to have an insignificant effect on either the flow rate or back pressure 
measurements over the period of time that each experiment was conducted. 
 
Supernatant Haemoglobin Measurement 
The hemoglobin detection limit of the recommended International Council for 
Standardisation in Haemotology (ICSH) standard method (1995)28 (ICSH-sm95) and the 
World Health Organisation29 was calculated to be too high for the accurate determination 
of haemoglobin released from lysed erythrocytes during the pumping of whole blood. 
Accordingly, a modified version of the ICSH-sm95 (described subsequently) was 
employed to determine the haemoglobin present in the whole blood sample. 
Sample pre-treatment and haemoglobin analysis methodology are briefly detailed 
below. 
Erythrocyte lysis is conveniently evidenced by the release of the erythrocytes’ 
haemoglobin-rich stroma into the suspending (supernatant) phase. Accordingly, 
subsequent to pumping, the cells in both the pumped blood samples and the reference 
samples were spun-down in the same centrifuge operation at 2000 rpm for 2 minutes in 
order to rapidly sediment the cells and allow us to remove cell-free samples of 
supernatant. 
Once the supernatant was removed from the centrifuged samples, Drabkin’s reagent 
(Sigma-Aldrich) was added in the ratio 25.1 parts to 1 part supernatant to convert all 
haemoglobin to its stable cyanohaemoglobin form30.  After leaving to react for 5 minutes, 
the solution was then centrifuged for 15 minutes at 2000 rpm to sediment the majority of 
the cellular debris.  0.22 µm pore size, low protein interaction filters (Millex, PVDF 
Membrane, Millipore) were then used to remove any remaining particulate matter and 
cell debris.  Measurements of the absorbance were then made at 540 nm using a Jenway 
6300, UV/Visible spectrophotometer (Jenway, Dunmow, UK) with cuvettes having a 
path length of 10 mm. 
All pumped and reference whole blood samples were prepared, using the methodology 
described above, prior to any absorbance measurements being made.  This reduced the 
likelihood of any variation in the absorbance measurements resulting from external 
conditions.  Following the measurement of all sample absorbances, the equation provided 
by Zwart et al (1996)28, adjusted to account for the difference in the dilution factor 
resulting from modifying the ICSH-sm95, was used to calculate the concentration of 
haemoglobin in both the reference and the pumped whole blood samples. The difference 
in the calculated haemoglobin concentration between the pumped whole blood sample 
and the associated reference sample was then used to determine the percentage 
erythrocyte lysis. 
Results 
Blood Pumping 
 
Figure 4. LMTP water and blood pumping rates as a function of drive frequency. 
Figure 4 displays pumping rate as a function of driving frequency for both water and 
whole blood. It can be seen that the pumping rate characteristics with water are similar to 
those previously reported21,24, with pumping rate reducing at approximately 700 Hz due 
to structural resonances in the LMTP device. However the pump rates achieved with 
whole blood display a much ‘flatter’ pump rate / frequency relationship. Maximum 
pumping rates of 1150 µl.min-1 (at 1800 Hz) for water and 204 µl.min-1 (at 1700 Hz) for 
whole blood were achieved. The ability of the LMTP to pump against a back pressure is 
shown in Figure 5. Although there is a considerable difference between the maximum 
back-pressures for water (40 kPa) and whole blood (25 kPa) the peak back-pressures, 
with blood, represent a considerable improvement over previously reported 
micropumps10,12. 
Blocking or gradual reduction in efficacy of the majority of micropumps and 
microvalves is a significant problem when the solution being pumped contains suspended 
phase particles19,31. Micropumps, that are particle tolerant, tend not to feature completely 
closing microvalves as integral components due to particles preventing full closure of the 
valve19, thereby reducing the micropump’s efficiency.  Peristaltic and non-mechanical 
micropumps have been developed that are capable of pumping particle laden solutions. 
However the reported back pressures and flow rates tend to be significantly lower than 
the LMTP reported here12,16,32,33. As previously stated, the LMTP has been demonstrated 
to be able to pump a solution containing a high concentration of suspended particles22. 
However, further consideration also indicates that particle tolerance does not necessarily 
correlate with, although it is required for, cell tolerance33. Therefore specific attention 
was paid to any potential sign of blocking.  During a total blood pumping time in excess 
of one hour no visible sign of blockage or cell adhesion was observed.  That time 
represented all blood pumping required for the measurement of the flow rate / actuator 
frequency relationship and yielding samples for the percentage erythrocyte lysis 
calculations.   
Cell Lysis 
The ICSH recommends the use of Drabkin’s Reagent for analysis of free haemoglobin 
and almost all derivatives29.  A mixture of potassium cyanide, potassium ferricyanide and 
a non-ionic detergent, Drabkin’s reagent reacts with all haemoglobin, excepting 
sulfhaemoglobin, to convert it to cyanohaemoglobin.  Cyanohaemoglobin being more 
stable than haemoglobin and possessing only one spectral absorbance peak, in contrast to 
Figure 5. LMTP water and blood back-pressure as a function of drive frequency. 
the multiple peaks produced by the derivatives of haemoglobin molecules found in blood, 
is a more straightforward spectrophotometric analyte than native haemoglobin. 
The detection limit of the ICSH-sm95 was calculated to be 1.10 g/l of 
cyanohaemoglobin for the spectrophotometer used: a value that was anticipated to be too 
high.  Accordingly we modified the ICSH-sm95 by increasing the sample volume of 
Drabkin’s reagent added to the sample, thereby reducing the dilution factor from 
approximately 4x10-3 to approximately 4x10-2, resulting in a factor of 10 increase in the 
cyanohaemoglobin concentration and therefore absorbance, relative to the background 
absorbance.  The modified ICSH-sm95 was validated by comparing the 
cyanohaemoglobin concentrations of serum samples, obtained by centrifuging and 
filtering whole blood, and serially diluted whole blood with those obtained using the 
ICSH-sm95, as shown in Figure 6.  The serum samples provided representative blanks.  
Absorbance was observed to increase linearly with concentration for the modified ICSH-
sm95 and a detection limit of 0.11 g/l was calculated for cyanohaemoglobin.  This is 
equivalent to approximately 0.1% of the whole blood haemoglobin concentration.  
Results obtained by comparing the modified ICSH-sm95 and standard ICSH-sm95 
differed by less than the experimental error of the ICSH-sm95 within the concentration 
range over which both analyses were valid. 
 
 Greater volumes of whole blood were required to be pumped for measurements of 
percentage lysis than for measurements of flow rate at each frequency. All measurements 
of percentage lysis demanded a minimum volume of 3 ml. Preliminary measurements 
were attempted using commercially available sheep blood.  However erythrocyte lysis in 
transit was such that any lysis occurring as a result of the LMTP operation was masked. 
Therefore the decision was made to use human blood from a local, healthy donor. To 
prevent agglutination human blood obtained from a single donor within the hour prior to 
the measurements was used. Even at peak flow rate, pumping sufficient blood to measure 
percentage lysis required 15 minutes.  Significant effort was made to ensure 
measurements were made as rapidly as possible following blood being drawn.  Therefore, 
in order to prevent artifacts being introduced in the percentage lysis measurements, as a 
result of significant variation in time ex-vivo, and considering that flow rate 
Figure 6. Calibration plots demonstrating the linear response of the absorbance, resulting from the ICSH-
sm95 and the modified ICSH-sm95, to diluted whole blood.  The slopes of the modified and standard 
methods are 0.03 and 0.003 respectively with an r2 of 0.9999 for both.  Cuvette path length was 10 mm. 
measurements were required to be taken prior to analysis of erythrocyte lysis, the number 
of measurements of percentage lysis were necessarily limited. Accordingly measurements 
of the proportion of erythrocytes lysed during the pumping of whole blood were made at 
selected drive frequencies and voltages based on previous MTP experience.  Peak flow 
rate was observed at a drive frequency of approximately 1800 Hz and voltage of 180 V.  
Measurements of percentage lysis were made at the peak flow rate conditions and at half 
the peak drive frequency and roughly half the drive voltage to independently determine 
the proportional effect on erythrocyte lysis of these changes.  The results obtained are 
presented in Table 1 below. 
 
 
 
 
 
 
Reducing the drive frequency from 1800 Hz to 900 Hz reduces the pumping rate by 
50%, but as shown in Table 1 the proportion of lysed cells is reduced by about 70%.  In 
comparison, a drive voltage of 100 V decreases both the pump rate and the erythrocyte 
lysis proportionately by about 70%.  
Discussion 
As Figure 4 illustrates, between pumping frequencies of (200 – 1800) Hz, a ratio of 1:9, 
the pumping rate of blood approximately doubles.  However, water increases by 
approximately ten times over the same frequency range.  This indicates that, when 
pumping rheologically Newtonian water, each pump stroke displaces a broadly constant, 
pump-frequency independent, volume of water.  However when pumping non-Newtonian 
blood the displaced volume per pump stroke declines with pumping frequency 
(nonetheless, increasing pumping frequency slightly offsets this to result in a small net 
increase in pumping rate with pumping frequency). 
It follows from the preceding argument that the energy invested into the pumped fluid, 
per volume of liquid pumped with each pump stroke, is effectively pump-rate 
independent in the case of water, but is strongly pump-rate dependent in the case of 
blood.  We would expect that cell lysis is proportional to the energy invested per unit 
pumped volume and would be spatially concentrated in the maximum energy density 
liquid regions of high, time dependent, shear associated with the microthrottles.  
Accordingly, given the higher energy invested per unit volume of pumped blood at higher 
pumping frequencies, we would anticipate increased erythrocyte lysis at such frequencies.  
Examining erythrocyte lysis data in Table 1. we find that, for the same drive voltage, and 
hence energy invested per pump stroke, erythrocyte lysis more than triples with a 
doubling in frequency from 900 Hz to 1800 Hz.  Likewise for iso-frequency conditions 
with increased drive voltage, and hence energy per pump stroke, erythrocyte lysis again 
more than triples as voltage is increased from 100 V to 180 V. 
Further formal development of LMTP blood pumping would benefit from a deeper 
theoretical understanding of blood flow behaviour within the LMTP throttle area.  This 
may allow an explanation of blood’s pumping rate / frequency function.  However, it is 
anticipated that this would be quite challenging in view of the microthrottle gap being 
comparable to a few erythrocyte diameters32, indicating that assuming bulk rheological 
properties for blood in the high shear region would be questionable: the dimensions, and 
hence anticipated micro-rheology, are comparable to the physiological microvasculature.  
Drive Frequency (Hz) Voltage (Vpk-pk) Percentage erythrocytes 
lysed 
Pump Rate (µl.min-1) 
1800 180 0.7 198 
1800 100 0.2 56 
900 180 0.2 102 
Table 1.: Results of measurements of erythrocyte lysis following pumping at selected PZT drive frequencies 
and voltages. 
Formal analysis of such dynamic micro-rheological behaviour would prove challenging 
due to erythrocytes having a non-trivial, bi-concave, discoidal morphology35 and 
furthermore their functionally deforming under the influence of fluid shear36, thus 
modifying their contributions to local micro-rheology in the vicinity of the microthrottles. 
Conclusions 
We have demonstrated continuous pumping of whole, undiluted, anti-coagulated, 
venous blood in an LMTP micropump (Figure 7, enhanced). The LMTP's operation has 
been confirmed to be blood-compatible, in the context of cell lysis, by assessing 
percentage erythrocyte lysis by means of haemoglobin release into the supernatant. 
Analysis-limited lysis levels of less than one erythrocyte in five hundred were recorded at 
a pump rate of 102 µl.min-1. Apart from indicating low levels of cell mechanical stress as 
a property of this type of micropump, such low levels of lysis may be beneficial to 
downstream on-chip cell processing functions such as PCR: a process that is 
compromised by haemoglobin contamination34. 
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